HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Study shows antiviral drugs could offer protection against HIV, Ebola, herpes and hepatitis C

The development of antibiotics gave physicians seemingly miraculous weapons against infectious disease. Effective cures for terrible afflictions like pneumonia, syphilis and tuberculosis were suddenly at hand. Moreover, many of the drugs that made them possible were versatile enough to knock out a wide range of deadly bacterial threats.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

Obama's budget to boost Medicaid funding, broaden global health approach

President Obama's budget proposal tops $3.8 trillion, and would draw a $1.3 trillion shortfall in 2011 despite efforts to freeze and cut spending and channel an extra $100 billion to immediately attack the high unemployment rate, The Washington Post reports.

2 Feb 2010

Serious liver disorder associated with use of HIV drug, FDA warns

The U.S. Food and Drug Administration today announced that non-cirrhotic portal hypertension, a rare, but serious, liver disorder, has been reported in some HIV patients taking Videx/Videx EC (didanosine).

2 Feb 2010

Researchers identify antiviral small molecule that is effective against numerous viruses

Viruses are insidious creatures. They differ from each other in many ways, and they can mutate - at times seemingly at will, as with HIV - to resist a host of weapons fired at them. Complicating matters further is that new viruses are constantly emerging.

2 Feb 2010

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.

2 Feb 2010

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

1 Feb 2010

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.

1 Feb 2010

Breakthrough in HIV research leads to better treatment potential

Researchers have made a breakthrough in HIV research that had eluded scientists for over 20 years, potentially leading to better treatments for HIV, in a study published today in the journal Nature.

31 Jan 2010

Artists and social agencies collaborate to deliver services for needy people

Black history will be made on Thursday, February 4th at Arthur Bennett Hall in Brooklyn with the opening of "Artists Speaking for the Spirits," an exhibition of mural-sized paintings by 40 artists of African ancestry.

30 Jan 2010

New vaccine effective in preventing TB in HIV patients

Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection.

30 Jan 2010

Recent releases in Global Health

Rajiv Shah's appointment as USAID administrator "comes at a crucial time of challenge and opportunity for the Agency to improve the nutritional well-being of impoverished societies," write the authors of a Lancet Comment that examines the U.S. Global Hunger and Food Security Initiative. Though the initiative "sends a clear message to the world about U.S. intent to partner with poor nations to achieve their national food and nutrition goals … the Initiative's nutrition plan, unlike its detailed agricultural blueprint, currently lacks a comprehensive set of aims, activities, research needs, and programme benchmarks," the authors write.

29 Jan 2010

Findings could guide in developing more effective vaccines for HIV/AIDS and cancer

In an acute viral infection, most of the white blood cells known as T cells differentiate into cells that fight the virus and die off in the process. But a few of these "effector" T cells survive and become memory T cells, ensuring that the immune system can respond faster and stronger the next time around.

29 Jan 2010

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Tibotec Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has approved a labeling update for PREZISTA® (darunavir) tablets to include 96-week data from the ARTEMIS and TITAN studies.

29 Jan 2010

Obama fails to announce new approaches for tackling global HIV/AIDS crisis, says Global AIDS Alliance

In tonight's State of the Union Address President Obama failed to announce any new approach to America's role in the world, instead sticking to vague rhetoric about development, the global HIV/AIDS crisis, and other global health priorities.

28 Jan 2010

AHF to conduct HIV testing events in Texas

AHF’s Magic Johnson ‘Testing America’ Tour, a six-month, 48-state national cross-country HIV testing tour, will ride into San Antonio, Texas, for two days of testing events at two Walgreens location.

28 Jan 2010

Centering Healthcare Institute receives the Cares Award for its CenteringPregnancy Group Prenatal Care program

Centering Healthcare Institute has been honored by the Premier healthcare alliance with the 18th Annual Monroe E. Trout Premier Cares Award for its CenteringPregnancy Group Prenatal Care program, which provides an innovative prenatal group care model now present in more than 300 sites across America. Centering Healthcare Institute last night received the Cares Award and $70,000 for the work it has done to provide care to mothers and babies nationwide.

28 Jan 2010

Alzheimer's disease becomes center of discussion at the World Economic Forum

For the first time ever, Alzheimer's disease is a focus at the World Economic Forum. Today more than 35 million people worldwide have dementia and those numbers will double every 20 years to 65.7 million in 2030 and 115.4 million in 2050, according to the World Alzheimer's Report from Alzheimer's disease International (ADI), a London-based, nonprofit, international federation of 71 national Alzheimer organizations.

28 Jan 2010

Formatech donates $308K in aseptic liquid fill and finish manufacturing services

Formatech continues its pledge to give back and make a difference in the biotechnology and pharmaceutical community with its Fillanthropy Program. Since the program’s inception, Formatech has donated $308K in aseptic liquid fill and finish manufacturing services to companies developing new drug therapies.

28 Jan 2010

Particle Sciences to share responsibilities in developing anti-HIV microbicides

Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV.

28 Jan 2010

HIV/AIDS News and Research

Further Reading

Study shows antiviral drugs could offer protection against HIV, Ebola, herpes and hepatitis C

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

Obama's budget to boost Medicaid funding, broaden global health approach

Serious liver disorder associated with use of HIV drug, FDA warns

Researchers identify antiviral small molecule that is effective against numerous viruses

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Breakthrough in HIV research leads to better treatment potential

Artists and social agencies collaborate to deliver services for needy people

New vaccine effective in preventing TB in HIV patients

Recent releases in Global Health

Findings could guide in developing more effective vaccines for HIV/AIDS and cancer

Labeling update for Tibotec Therapeutics' PREZISTA tablets approved

Obama fails to announce new approaches for tackling global HIV/AIDS crisis, says Global AIDS Alliance

AHF to conduct HIV testing events in Texas

Centering Healthcare Institute receives the Cares Award for its CenteringPregnancy Group Prenatal Care program

Alzheimer's disease becomes center of discussion at the World Economic Forum

Formatech donates $308K in aseptic liquid fill and finish manufacturing services

Particle Sciences to share responsibilities in developing anti-HIV microbicides

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News